I thought I'd die by 30, now I'm rowing the Atlantic
Sophie Pierce is determined to make the most of her life - however long she may have.
Baylor College of Medicine4y
Cystic Fibrosis Center
The Baylor Medicine Maconda Brown O'Connor, Ph.D., Adult Cystic Fibrosis Center provides the highest quality care in a compassionate, patient-centered setting. Our center, which is accredited by the ...
Medscape4d
Inhaled Morphine for Palliation of Dyspnea in End-stage Cystic Fibrosis
The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF ... due to the lack of large-scale clinical trials.
BBC1y
Kaftrio: Parents fear loss of cystic fibrosis 'miracle drug'
Alice Cystic fibrosis symptoms usually start in early childhood ... NICE said an independent committee was looking into the clinical and cost effectiveness of using Kaftrio. It said the review ...
Joplin Globe16d
Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis
Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis ...
Nature2y
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
In 1997, the National Institutes of Health convened a Consensus Development Conference on Cystic Fibrosis (CF ... CF carrier screening and to develop “Clinical and Laboratory Provider Guidelines ...
Too Old to Operate14d
An update on multiple breath washout in children with cystic fibrosis.
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CF transmembrane regulator (CFTR) gene, leading to progressive lung disease and systemic complications. Lung disease ...
precisionmedicineonline13d
FDA Approves New 'Vanza Triple' Cystic Fibrosis Drug From Vertex, Expands Label for Trikafta
Alyftrek is approved as a new treatment for cystic fibrosis, while the FDA expanded the label for Trikafta to include additional genetic mutations.